Tiopronin 100mg, 300mg; del-rel tabs. Tiopronin is an active reducing agent that undergoes thiol-disulfide exchange with cystine to form a mixed disulfide of tiopronin-cysteine. From this reaction, a ...
A new enteric-coated formulation of Thiola has been approved by the Food and Drug Administration for the prevention of cystine stone formation. A new enteric-coated formulation of Thiola (tiopronin; ...
The US Food and Drug Administration (FDA) has approved an enteric-coated delayed-release formulation of tiopronin (Thiola EC, Retrophin) for treatment of cystinuria, a rare inherited disorder that ...
Endo is introducing Tiopronin delayed-release tablets, a generic version of Travere Therapeutics' Thiola EC. The medication is used in combination with high fluid intake, alkali (low acid) and dietary ...
MALVERN, Pa., July 15, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today the launch of tiopronin delayed-release tablets, a generic version of Travere Therapeutics' THIOLA EC®. "We're ...
FDA clearance of Retrophin Inc.'s enteric-coated (EC) version of Thiola (tiopronin) 100-mg and 300-mg tablets for cystinuria – a rare, inherited disorder that causes levels of cystine to build up in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results